Whalesbook
Valuation Adjusts to Focus on Underwriting
ICICI Lombard General Insurance is being reassessed amid changing market conditions. ICICI Securities has reaffirmed its 'BUY' rating, keeping the target price at INR 2,250, showing continued confidence in the company's long-term prospects. This is supported by a change in how its value is calculated, now using a 28x multiple on projected FY28 earnings per share (EPS) of INR 79.4. This reflects an improved underwriting outlook, shifting focus from investment income to core business profits. The company's market value is about INR 94,300 crore. Its P/E ratio is around 34.0x, higher than the industry average of 16.70x. This higher valuation suggests investors expect strong future growth. The stock is trading around INR 1,860, near its 52-week low. Recent Q4 FY26 net profit rose 7.3% year-on-year to INR 547 crore, with gross direct premiums growing 18.2%, outpacing industry growth. However, its combined ratio improved to 101.2% in Q4 FY26, still above the 100% breakeven point, meaning it still relies on investment gains to be profitable.
Industry Trends: Challenges and Opportunities
The general insurance sector faces challenges like slower growth in motor insurance and higher claims costs. Despite these pressures, ICICI Lombard is well-placed to benefit from positive trends. The health segment is a key growth driver, boosted by rising market share and better returns on equity (RoE). In Q3 FY26, health segment premiums jumped 42% year-on-year, and retail business grew 85.8%, both far exceeding industry growth. Overall, ICICI Lombard's premiums grew 13.3% in Q3 FY26, slightly above the industry's 11.5%. A potential increase in motor third-party (TP) premiums and lower Goods and Services Tax (GST) could also boost growth and profit margins. Competitors like Bajaj Allianz General Insurance and HDFC ERGO have P/E ratios between 31x and 40x. With an estimated 9.9% market share, ICICI Lombard is focused on digital tools and diverse products to capture growth in India's expanding insurance market.
Potential Risks and Challenges
However, some risks could temper this positive outlook. A primary concern is its ongoing reliance on investment income to cover underwriting losses, with the combined ratio still over 100%. Losses from market fluctuations in its stock holdings have affected profits, as shown in Q4 FY26 results. The general insurance market is highly competitive, with many more private insurers now operating. This can strain pricing and profits, particularly in the slow-growing motor segment. Unexpected increases in health claims or slower industry growth could also affect earnings forecasts. While its solvency ratio is strong at 2.67x, above the regulatory minimum, the stock has been flat over the past year. Its Price-to-Book ratio of 5.6x is also higher than some rivals, which could limit gains if growth slows. There's also a risk that future growth targets, which drive the revised FY28 earnings, are too optimistic.
Analyst Views and Future Prospects
Looking ahead, ICICI Lombard plans to use its focus on retail health and steady premium growth to boost profits. Analysts expect earnings to grow at a compound annual rate of 16.1% from FY25 to FY28E, possibly reaching INR 40 billion in net profit by FY28E. The company targets an RoE of 18-20%, showing a strong return for shareholders. Most analysts (26) rate it 'Buy', with an average 12-month target of INR 2,118, suggesting over 12% upside. JPMorgan and HSBC rate it 'Buy' with targets around INR 2,170 and INR 2,200, while Citi is 'Sell'. Management is confident in capturing market demand through steady growth, better customer offerings, and wider reach.